INSL3 B chain dimer analogue 8 [4185]
INSL3 B chain dimer analogue 8
| SMILES |
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C |
| InChIKey |
RSEFVJQOZGIWEG-VBMLHUJMSA-N |
| Sequence |
CGHHFVRALVRVC |
| HELM |
PEPTIDE1{C.G.H.H.F.V.R.A.L.V.R.V.C}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
20 |
| Hydrogen bond donors |
22 |
| Rotatable bonds |
46 |
| Log P |
-4.978 |
| Molecular weight (Da) |
1495.8 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
INSL3 B chain dimer analogue 8
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.